Verus Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Verus Capital Partners's AMGN Position: Q2 2026 in Review
Verus Capital Partners increased its Amgen (AMGN) stake by 8.8% in Q2 2026, buying an estimated $34.9K and bringing the position to 1,263 shares worth $457K. The position accounts for 0.02% of the portfolio, ranked #318.
Verus Capital Partners first reported a position in AMGN in Q4 2019 and has held it in 20 quarters since. The position peaked at $746K in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Verus Capital Partners held 1,263 shares of Amgen worth $457K as of Q2 2026.
- Verus Capital Partners bought 102 Amgen shares in Q2 2026, an estimated $34.9K.
- Amgen made up 0.02% of Verus Capital Partners's portfolio in Q2 2026, its #318 holding.
- Verus Capital Partners first reported a position in Amgen in Q4 2019 and has held it in 20 quarters since.
- Verus Capital Partners's Amgen position peaked at $746K in Q3 2024.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.